The Inaugural Frank Ellis Lecture - Iatrogenic Cancer: The Impact of Intensity-modulated Radiotherapy

Clinical Oncology

Volumn 18, Issue 4, 2006, Pages 277-282

  Hall, E J ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

IMRT; leakage radiation; passive modulation; pencil beams; protons; second cancers

Indexed keywords

ARTICLE; BLADDER CANCER; BONE CANCER; BONE MARROW CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER RADIOTHERAPY; CHILD CARE; CHILDHOOD CANCER; COLON CANCER; DISEASE CONTROL; ESOPHAGUS CANCER; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL EDUCATION; METASTASIS; MODULATION; NEUTRON RADIATION; OVARY CANCER; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RADIATION INJURY; RADIATION SCATTERING; SKIN CANCER; STOMACH CANCER; THYROID CANCER; TUMOR GROWTH; TUMOR VOLUME; X RAY;

CHILD; HUMANS; IATROGENIC DISEASE; NEOPLASMS; RADIATION DOSAGE; RADIATION ONCOLOGY; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; RISK FACTORS; SURVIVORS;

EID: 33645854067     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.02.006     Document Type: Article

References (19)

1. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy current status and issues of interest. Int Radiat Oncol Biol Phys 51 (2001) 880-914
2. Followill D., Geis P., and Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 38 (1997) 667-672
3. Verellen D., and Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body dose equivalent estimates for IMRT in the head and neck region. Radiother Oncol 53 (1999) 199-203
4. Hall E.J., and Wuu C. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
5. Kry S.F., Salehpour M., Followill D., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1195-2003
6. Pierce D.A., Shimuzu Y., Preston D.L., Vaeth M., and Mabuchi K. Studies of the mortality of atomic bomb survivors: Report 12, Part 1. Cancer: 1950-1990. Radiat Res 146 (1996) 1-27
7. NCRP Report 116. Limitation of exposure to ionizing radiation (1993), National Council on Radiation Protection and Measurements, Bethesda, MD
8. Boice Jr. J.D., Engholm G., Kleinman R.A., et al. Radiation dose and second cancers risk in patients treated for cancer of the cervix. Radiat Res 116 (1988) 3-55
9. Brenner D.J., Curtis R.E., Hall E.J., and Ron E. Second malignancies in prostate patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-406
10. Nyandoto P., Muhonen T., and Joensuu H. Second cancers among long-term survivors from Hodgkin's disease. Int J Radiat Oncol Biol Phys 42 (1998) 373-378
11. Williams P.C., and Hounsell A.R. X-ray leakage considerations for IMRT. Br J Radiol 74 (2001) 98-102
12. Gray L.H. Radiation biology and cancer. Cellular radiation biology: a symposium considering radiation effects in the cell and possible implications for cancer therapy: a collection of papers (1965), William and Wilkins, Baltimore 8-25 (published for the University of Texas MD Anderson Hospital and Tumor Institute)
13. International Commission on Radiological Protection. Recommendations. Annals of the ICRP Publication 60 (1990), Pergamon Press, Oxford
14. Guibout C., Adjadj E., Rubino C., et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 23 (2005) 197-204
15. Smilenov L.B., Brenner D.J., and Hall E.J. Modest increased sensitivity to radiation oncogenesis in ATM heterozygous versus wild-type mammalian cells. Cancer Res 61 (2001) 5710-5713
16. Smilenov L.B., Lieberman H.B., Mitchell S.A., et al. Combined haploinsufficiency for ATM and RAD9 as a factor in cell transformation, apoptosis, and DNA lesion repair dynamics. Cancer Res 65 (2005) 933-938
17. Kim J.O., Siebers J.V., Keall P.J., Arnfield M.R., and Mohan R. A Monte Carlo study of radiation transport through multileaf colloimators. Med Phys 12 (2001) 2497-2506
18. Schneider U., Agosteo S., Pedroni E., and Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys 53 (2002) 244-251
19. Yan X., Newhauser W.D., Titt U., and Koehler A.M. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nucl Instrum Methods A476 (2002) 429-434